Intrinsiqs

Is Corbus Pharmaceuticals Holdings, Inc. overvalued?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) — key valuation metrics and fundamentals.

No verdict
Price
$10.09
Fair value
Current P/E
Normal P/E
Market cap
$186.9M
Dividend yield
0.0%
Return on equity
-87.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CRBP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.